Article
SRSF3 knockdown-induced cellular senescence as a possible therapeutic strategy for non-small cell lung cancer
2025-05-09
Abstract excerpt
Tyrosine kinase (TK) inhibitors improve clinical outcomes in non-small cell lung cancer (NSCLC) with targetable mutations. However, such NSCLC cases only consist of about 50% in the western populations. This study, for the first time in NSCLC cells including those without a targetable TK mutation, explores a tumor-suppressive activity of siRNA knockdown of a splicing factor SRSF3, which was reportedly effective in...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c2f4d486-870d-5848-87ee-9ec23908e5fa
- DOI
- 10.1101/2025.05.05.652234
